Literature DB >> 10397978

Mineralization of glutaraldehyde-fixed porcine aortic valve cusps in the subcutaneous rat model: analysis of variations in implant site and cuspal quadrants.

W J Mako1, A Shah, I Vesely.   

Abstract

When evaluating the efficacy of new antimineralization treatments for bioprosthetic heart valves, subcutaneous implantation in a rat model often is used as an initial test. Although this model is widely used, there still are many aspects of its implementation that have not been investigated. To further investigate several parameters that may affect mineralization in the subcutaneous rat model, portions of glutaraldehyde-treated porcine aortic valve cusps were implanted both ventrally and dorsally into 21-day-old male Sprague-Dawley rats. Cusp quadrants were explanted at 1,2, and 3 weeks postimplantation and the calcium levels determined by atomic absorption spectroscopy. The objective of this study was to determine whether or not different implant locations and/or regions of the cusps affect the degree to which tissue mineralizes in the subcutaneous rat model. A total of 270 tissue specimens were examined. While the specific portion of the cusp implanted did not significantly affect the degree of mineralization, dorsal implantation resulted in significantly more mineralization than abdominal implantation (p = 0.007). As expected, longer implantation time was associated with greater calcification (p = 0.0001). The results of this study indicate that inconsistent placement of tissues in the rat subcutaneous implant model can result in significant differences in the degree of mineralization. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397978     DOI: 10.1002/(sici)1097-4636(19990605)45:3<209::aid-jbm8>3.0.co;2-n

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  In vivo biomechanical assessment of triglycidylamine crosslinked pericardium.

Authors:  Michael S Sacks; Hirotsugu Hamamoto; Jeanne M Connolly; Robert C Gorman; Joseph H Gorman; Robert J Levy
Journal:  Biomaterials       Date:  2007-09-05       Impact factor: 12.479

2.  Assessing anticalcification treatments in bioprosthetic tissue by using the New Zealand rabbit intramuscular model.

Authors:  Gregory A Wright; Joelle M Faught; Jane M Olin
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

3.  The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration.

Authors:  Thomas Senage; Anu Paul; Thierry Le Tourneau; Imen Fellah-Hebia; Marta Vadori; Salam Bashir; Manuel Galiñanes; Tomaso Bottio; Gino Gerosa; Arturo Evangelista; Luigi P Badano; Alberto Nassi; Cristina Costa; Galli Cesare; Rizwan A Manji; Caroline Cueff de Monchy; Nicolas Piriou; Romain Capoulade; Jean-Michel Serfaty; Guillaume Guimbretière; Etienne Dantan; Alejandro Ruiz-Majoral; Guénola Coste du Fou; Shani Leviatan Ben-Arye; Liana Govani; Sharon Yehuda; Shirley Bachar Abramovitch; Ron Amon; Eliran Moshe Reuven; Yafit Atiya-Nasagi; Hai Yu; Laura Iop; Kelly Casós; Sebastián G Kuguel; Arnau Blasco-Lucas; Eduard Permanyer; Fabrizio Sbraga; Roger Llatjós; Gabriel Moreno-Gonzalez; Melchor Sánchez-Martínez; Michael E Breimer; Jan Holgersson; Susann Teneberg; Marta Pascual-Gilabert; Alfons Nonell-Canals; Yasuhiro Takeuchi; Xi Chen; Rafael Mañez; Jean-Christian Roussel; Jean-Paul Soulillou; Emanuele Cozzi; Vered Padler-Karavani
Journal:  Nat Med       Date:  2022-02-17       Impact factor: 87.241

4.  Suitability of the rat subdermal model for tissue engineering of heart valves.

Authors:  Torsten Christ; Pascal M Dohmen; Sebastian Holinski; Melanie Schönau; Georg Heinze; Wolfgang Konertz
Journal:  Med Sci Monit Basic Res       Date:  2014-12-10

5.  Histologic Assessment of Drug-Eluting Grafts Related to Implantation Site.

Authors:  Jean-Christophe Tille; Sarra de Valence; Delia Mandracchia; Benjamin Nottelet; Francesco Innocente; Robert Gurny; Michael Möller; Beat H Walpoth
Journal:  J Dev Biol       Date:  2016-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.